Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMK9S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,949
Award facts
- Contract value 100% obligated
- $12,949.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,949.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml quantities. The contract is set to conclude on February 2, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements through open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. Ozempic, a diabetes medication, represents one of the diverse pharmaceutical products delivered through this flexible contracting vehicle to support military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FMK9S?
SPE2DR26FMK9S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FMK9S worth?
The government has obligated $12,949 on SPE2DR26FMK9S.
Is contract SPE2DR26FMK9S an order under another contract?
Yes. SPE2DR26FMK9S is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK9S competed?
The extent of competition for SPE2DR26FMK9S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award